Obsidian Therapeutics

The next generation of engineered therapeutics

Cambridge, United States · Founded 2015 · $325.0M raised

Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$325.0M
Last Round
$160.5M Series CApr 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 14 investors for this company. The full record is or through the API.

About

Obsidian Therapeutics is a clinical-stage biopharmaceutical company pioneering engineered cell and gene therapies using its proprietary cytoDRiVE platform, which enables precise, patient-specific control of therapeutic proteins. The company's TIL and adoptive cell therapy programs for cancer have scientific roots in Stanford University's Wandless Lab.

Summary

Obsidian Therapeutics is a Biotech company based in Cambridge, United States, founded in 2015. It has raised $325.0M in total across 3 rounds, most recently a $160.5M Series C round in Apr 2024. Investors include Wellington Management, GV and Atlas Venture.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CApr 2024
$160.5M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Obsidian Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/obsidian-therapeutics"><img src="https://indexed.vc/api/badge/company/obsidian-therapeutics" alt="Obsidian Therapeutics on Indexed.vc" width="260" height="76" /></a>